ChemicalBook > Product Catalog >API >Hormones and the Endocrine System >Pancreatic hormone and blood sugar regulation >Flibanserin
Flibanserin
- CAS No.
- 167933-07-5
- Chemical Name:
- Flibanserin
- Synonyms
- Filbanserin;Flibanserine;BIMT;Niemunerkeine;1,3-Dihydro-1-[2-[4-[3-(trifluoromethyl)phenyl]-1-piperazinyl]ethyl]-2H-benzimidazol-2-one;Girosa;Bimt 17;BIMT 17BS;Fbanselin;Flibanerins
- CBNumber:
- CB91178756
- Molecular Formula:
- C20H21F3N4O
- Molecular Weight:
- 390.4
- MOL File:
- 167933-07-5.mol
- MSDS File:
- SDS
- Modify Date:
- 2024/9/25 14:54:50
| Density | 1.292±0.06 g/cm3(Predicted) |
|---|---|
| storage temp. | 2-8°C |
| solubility | DMSO: soluble10mg/mL, clear |
| form | powder |
| pka | 12.12±0.30(Predicted) |
| color | white to beige |
| InChI | InChI=1S/C20H21F3N4O/c21-20(22,23)15-4-3-5-16(14-15)26-11-8-25(9-12-26)10-13-27-18-7-2-1-6-17(18)24-19(27)28/h1-7,14H,8-13H2,(H,24,28) |
| InChIKey | PPRRDFIXUUSXRA-UHFFFAOYSA-N |
| SMILES | C1(=O)N(CCN2CCN(C3=CC=CC(C(F)(F)F)=C3)CC2)C2=CC=CC=C2N1 |
SAFETY
Risk and Safety Statements
| Symbol(GHS) |  GHS06 |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Signal word | Danger | |||||||||
| Hazard statements | H301-H315-H319-H335 | |||||||||
| Precautionary statements | P301+P310+P330-P302+P352-P305+P351+P338 | |||||||||
| Hazard Codes | T | |||||||||
| Risk Statements | 25-36/37/38 | |||||||||
| Safety Statements | 26-45 | |||||||||
| RIDADR | UN 2811 6.1 / PGIII | |||||||||
| WGK Germany | 3 | |||||||||
| NFPA 704 |
|
Flibanserin price More Price(2)
Flibanserin Chemical Properties,Uses,Production
Description
Flibanserin is a drug originally developed by Boehringer-Ingelheim and later Sprout Pharmaceuticals, which was approved in 2015 by the FDA for the treatment of premenopausal women with hypoactive sexual desire disorder (HSDD). The drug, which was originally developed for the treatment of depression by Boehringer- Ingelheim, is a full agonist of the 5-HT1A receptor, an antagonist of the 5-HT2A receptor, and a partial agonist of the dopamine-4 (D4) receptor, which triggers increased dopamine and norepinephrine levels along with decreased serotonin levels. In three randomized trials involving 2400 premenopausal women, the drug was found to increase the number of satisfying sexual events by 0.5-1.0 events per month and increased sexual desire on average by 10-12% over placebo. Side effects include decreased blood pressure and loss of consciousness, especially in subjects who consumed alcohol.
Uses
Antidepressant (5-HT1a agonist and 5-HT2 antagonist).
Flibanserin Preparation Products And Raw materials
Raw materials
Preparation Products
Global( 345)Suppliers
| Supplier | Tel | Country | ProdList | Advantage | Inquiry |
|---|---|---|---|---|---|
| Viyash Life Sciences Pvt Ltd | +91-4023635052 +91-4023635052 | Telangana, India | 213 | 58 | Inquiry |
| Apicore Pharmaceuticals Pvt Ltd | +91-2662267177 +91-2662267166 | Gujarat, India | 181 | 58 | Inquiry |
| Century Pharmaceuticals Ltd | +91-2652361581 +91-2652361581 | Gujarat, India | 53 | 58 | Inquiry |
| Symed Laboratories Ltd | +91-9505426644 +91-9505426644 | Telangana, India | 54 | 58 | Inquiry |
| TCI Chemicals (India) Pvt. Ltd. | 1800 425 7889 | New Delhi, India | 6778 | 58 | Inquiry |
| A.J Chemicals | 91-9810153283 | New Delhi, India | 6124 | 58 | Inquiry |
| CLEARSYNTH LABS LTD. | +91-22-45045900 | Hyderabad, India | 6351 | 58 | Inquiry |
| Pharmaffiliates Analytics and Synthetics P. Ltd | +91-172-5066494 | Haryana, India | 6773 | 58 | Inquiry |
| IHR Polytech LLP | 08046070046 | Ahmedabad, India | 3 | 58 | Inquiry |
| SynZeal Research Pvt Ltd | +1 226-802-2078 | Gujarat, India | 6522 | 58 | Inquiry |
Related articles
- Flibanserin: A Medication for Hypoactive Sexual Desire Disorder and Female Sexual Interest
- Flibanserin treats hypoactive sexual desire disorder by modulating serotonin and dopamine receptors, improving sexual desire. ....
- Feb 6，2024
- Flibanserin: pharmacokinetics, pharmacology, clinical applications and side effects
- Flibanserin enhances sexual desire in women by modulating neurotransmitter levels. Side effects include dizziness, sleepiness,....
- Aug 2，2023
- What is Flibanserin?
- Flibanserin is a novel multifunctional serotonin agonist and antagonist (MSAA) that improves sexual functioning in premenopaus....
- Feb 20，2020
167933-07-5(Flibanserin)Related Search:
chevron_left
1of4
chevron_right
Flibanserin,Bimt 17, Bimt-17-BS,Girosa
Flibanserin
Bimt 17
3-[2-[4-[4-(Trifluoromethyl)phenyl]piperazin-1-yl]ethyl]-1H-benzimidazol-2-one
Flibanerins
BIMT 17BS
2H-Benzimidazol-2-one,1,3-dihydro-1-[2-[4-[3-(trifluoromethyl)phenyl]-1-piperazinyl]ethyl]-
Flibanserin(BIMT17)
3-[2-[4-[3-(trifluoromethyl)phenyl]-1-piperazinyl]ethyl]-1H-benzimidazol-2-one
Flibaneserin
BIMT-17;BIMT-17BS
Flubensin (female)
Flibaserin(female)
Fbanselin
Flubanserin
crystal paracetamol Flibanserin CAS NO.167933-07-5
Girosa
Color Lin fluorine class
Flibanserin USP/EP/BP
Flibaserin USP/EP/BP
2-Flibanserin
Flibanserin ADDYI
Flibanserin powder
Filbanserin
1,3-Dihydro-1-[2-[4-[3-(trifluoromethyl)phenyl]-1-piperazinyl]ethyl]-2H-benzimidazol-2-one
Niemunerkeine
Flibanserine
BIMT
1-(2-(4-(3-(trifluoromethyl)phenyl)piperazin-1-yl)ethyl)-1H-benzo[d]imidazol-2(3H)-one
167933-07-5
C20H21F3N4O
API
API,chemical material